【24h】

Medical treatment of cataract.

机译:白内障的药物治疗。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The incidence of cataract continues to increase with the ageing of the population. Surgical treatment with phacoemulsification and intraocular lens implantation remains the only proven treatment. This, however, is associated with significant cost and is not readily available especially in the developing countries where the prevalence of cataract is the highest. Medical treatment of cataract is therefore a highly desired alternative. Since the last major review of medical treatment of cataract the search for an anti-cataract agent has advanced on many fronts. Some anti-cataract drugs, such as carnosine, have now reached clinical trials and showed encouraging results that warrant further investigation. The discovery of an effective medical treatment for cataract is likely to make global impact on eye health. The aims of this paper are to review the literature on the drug therapy of cataract and provide updates of the latest development.
机译:随着人口的老龄化,白内障的发生率继续增加。超声乳化和人工晶状体植入的外科手术治疗仍然是唯一经过验证的治疗方法。但是,这带来了巨大的成本,而且尚不容易获得,特别是在白内障患病率最高的发展中国家。因此,非常需要白内障的医学治疗。自从上次对白内障的药物治疗进行重大综述以来,在许多方面都在寻求抗白内障药物。一些抗白内障药物(例如肌肽)现已进入临床试验,并显示出令人鼓舞的结果,值得进一步研究。对于白内障的有效治疗方法的发现很可能对眼睛健康产生全球影响。本文的目的是回顾有关白内障药物治疗的文献并提供最新进展的更新。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号